SynthesisF1000Research2021

Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis.

Cahyo Wibisono Nugroho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.